FusionPharm Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on FusionPharm's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Food Industry Growth | 16.0% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 31 Mar 2012 |
Recent past performance updates
No updates
Recent updates
No updates
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, FusionPharm has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Show sectionRevenue & Expenses BreakdownBeta
How FusionPharm makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 12 | 0 | 0 | 0 | 0 |
Quality Earnings: FSPM has a high level of non-cash earnings.
Growing Profit Margin: Insufficient data to determine if FSPM's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if FSPM's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare FSPM's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if FSPM's earnings growth over the past year exceeded the Food industry average.
Return on Equity
High ROE: FSPM has a negative Return on Equity (0%), as it is currently unprofitable.